Archive for November, 2009
After talking with numerous medical professionals and asking friends about how they treated their prostate cancers, financial services executive Steve Henley opted to have a robotic-assisted laparoscopic prostatectomy. In this interview, he explains what factors went into that decision.
Study shows that taking both dutasteride (Avodart) and tamsulosin (Flomax) might be more effective at easing symptoms than taking just one.
Given the beneficial effects and the lack of a survival difference, intermittent hormone therapy may be a preferred regimen for men with advanced prostate cancer.
High levels of selenium in the blood are associated with a slightly higher-than-normal risk of aggressive prostate cancer.
A European study finds that mortality is higher among men who pursue hormone therapy for just six months. But the study was conducted in men with relatively large tumors, not small, early-stage tumors, the kind found most often in American men.
According to a 2007 Swedish study, a PSA test done between the ages of 44 and 50 may predict whether or not a man will develop prostate cancer later in life.
In a study of over 250 men, Swedish researchers found that neither the initial PSA level nor its rate of increase in a two-year period predicted which men had lethal versus indolent cancers.
Fifteen Harvard-affiliated physicians discuss their recommendations for PSA screening.
The U.S. Preventive Services task force announced in 2008 that doctors should stop testing men who are 75 or older. The panel also concluded that the benefit of screening in younger men is uncertain.
If your PSA has varied greatly and biopsies have been negative, you might want to try a different testing regimen.